Common Contracts

Executive Retention Agreement

Retention Agreement • November 7th, 2018 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah

• Contract Type
  Retention Agreement
• Filed
  November 7th, 2018
• Company
  Myriad Genetics Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Utah

THIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and ________________________ (the “Executive”), is made as of ___________, (the “Effective Date”).

MYRIAD GENETICS, INC. Executive Retention Agreement

Retention Agreement • November 4th, 2015 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah

• Contract Type
  Retention Agreement
• Filed
  November 4th, 2015
• Company
  Myriad Genetics Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Utah

THIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and (the “Executive”), is made as of , (the “Effective Date”).

MYRIAD GENETICS, INC. Executive Retention Agreement

Retention Agreement • February 4th, 2015 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah

• Contract Type
  Retention Agreement
• Filed
  February 4th, 2015
• Company
  Myriad Genetics Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Utah

THIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and R. Bryan Riggsbee (the “Executive”), is made as of December 18, 2014 (the “Effective Date”).

MYRIAD GENETICS, INC. Form of Executive Retention Agreement

Retention Agreement • May 5th, 2010 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah

• Contract Type
  Retention Agreement
• Filed
  May 5th, 2010
• Company
  Myriad Genetics Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Utah

THIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and (the “Executive”), is made as of February 17, 2005 (the “Effective Date”).

MYRIAD GENETICS, INC. Executive Retention Agreement

Retention Agreement • February 6th, 2007 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah

• Contract Type
  Retention Agreement
• Filed
  February 6th, 2007
• Company
  Myriad Genetics Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Utah

THIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and Mark C. Capone (the “Executive”), is made as of November 17, 2006 (the “Effective Date”).